Johnson Pharmacare Announcements
Disclosure as per Regulation 30 of SEBI (LODR) Regulation 2015
17 Apr, 2026 | 07:20pm • Source: BSE
Disclosure as per Regulation 30 of SEBI (LODR) Regulation 2015Appointment of MR. Nand Kishore Ray as Additional Non -Executive &Non- Independent Director and Appointment...
17 Apr, 2026 | 06:55pm • Source: BSE
1. The Board has appointed Mr. Nand Kishore Ray (DIN: 11626638) as an Additional(Non-Executive & Non-Independent Director) of the Company w.e.f 17th April, 2026 The...
17 Apr, 2026 | 06:08pm • Source: BSE
Certificate under Regulation 74(5) of SEBI ( Depositories and Participants) Regulations, 2018 for the quarter and year ended 31st March, 2026
13 Apr, 2026 | 05:49pm • Source: BSE
Intimation of Closure of Trading Window as per Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015 for the Quarter and Year...
21 Mar, 2026 | 05:00pm • Source: BSE
Submission of Extract of Newspaper Publication of Unaudited (Standalone) Financials Results for the quarter ended on 31st December 2025
16 Feb, 2026 | 03:37pm • Source: BSE
Disclosure as per Regulation 30 of SEBI (LODR) Regulations 2015 Appointment of Parul Agrawal as Additional (Non-Executive Independent Director) of the company.
13 Feb, 2026 | 01:58pm • Source: BSE
Disclosure under Regulation 30 of SEBI (LODR) regarding appointmrent of M/S VRSK & Associates as Statutory Auditors of the Company .
13 Feb, 2026 | 01:47pm • Source: BSE
1. The Board of Director have considered and approved the appointment of M/S. VRSK &Associates (FRN:011199N) as Statutory Auditor of the Company to fill the...
13 Feb, 2026 | 01:01pm • Source: BSE
Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and...
12 Feb, 2026 | 06:20pm • Source: BSE
Disclosure as per Regulation 30 of SEBI (LODR) Regulations, 2015Appointment of Mr. Umesh kumar as an Additional Executive Director of the company.
09 Feb, 2026 | 06:36pm • Source: BSE
The Board has appointed Mr. Umesh Kumar (DIN: 07015921) as an Additional ExecutiveDirector of the Company w.e.f 09th February, 2026 a brief profile pursuant to...
09 Feb, 2026 | 06:06pm • Source: BSE
Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and...
05 Feb, 2026 | 06:18pm • Source: BSE
Disclosure of Change of Corporate Office Pursuant to Regualtion 30 of the SEBI (LODR) Regulations 2015
02 Feb, 2026 | 04:56pm • Source: BSE
The board has considered and approve the removal of the Corporate Office ' 1002 10th Floor,Vikram Tower, Rajendra Place, New Delhi-110060., Rajender Nagar, Central Delhi,...
02 Feb, 2026 | 04:33pm • Source: BSE
Board Approved the appointment of Babita as an Non Executive & Independent Director w.e.f. 31st January 2026.
31 Jan, 2026 | 07:33pm • Source: BSE
Board Approved the Resignation of Mr. Umesh Kumar (DIN: 07015921) as an Additional & Executive Director
31 Jan, 2026 | 07:29pm • Source: BSE
The Board has appointed Ms. Babita (DIN: 09064124) as a Non-Executive & IndependentDirector of the Company w.e.f 31st January, 2026 a brief profile pursuant to...
31 Jan, 2026 | 07:02pm • Source: BSE
Pursuant to Regulation 30 of SEBI (LODR) Regulation 2025 there is change in directors of board MS. Babita (DIN: 09064124) Non Executive & Independent Director...
24 Jan, 2026 | 01:08pm • Source: BSE
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 the Board approved the appointment of Mr. Rajendra Prasad (DIN: 10871533) as an Additional & Non-Executive...
24 Jan, 2026 | 12:58pm • Source: BSE